MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-CH-01-0009354
Kenbrio Pharmaceuticals Private Limited
Kenbrio Pharmaceuticals Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.05 Cr
▼ 4% YoY
Net profit · FY 2024
₹3.31 Lakh
Net margin 3.1%
EBITDA · FY 2024
₹4.93 Lakh
EBITDA margin 4.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹20.1 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Kenbrio Pharmaceuticals Private Limited
Data last updated:
Kenbrio Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24299CH2016PTC041253. Its GSTIN is 04AAGCK3217Q1ZC (Chandigarh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Neeraj Kumar and Rakesh Singh Salaria.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 6 A Plot No. 181 Sp Rana Complex Village – Dadumajra, Chandigarh, India – 160014.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.05 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹3.31 Lakh (net margin 3.1%) and EBITDA of ₹4.93 Lakh (EBITDA margin 4.7%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years and 7% over five years.
As per MCA filings, the company has open charges of ₹20.1 Lakh on record.
Kenbrio Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0009354). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24299CH2016PTC041253
Registration Number 041253
Incorporation Date 13 October 2016
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-CH-01-0009354
Recognitions & Rankings of Kenbrio Pharmaceuticals
Contact details
Kenbrio Pharmaceuticals Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address is in the company report.
- Email
- Registered AddressShop No. 6 A Plot No. 181 Sp Rana Complex Village – Dadumajra, Chandigarh, India – 160014
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kenbrio Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Kenbrio Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Kenbrio Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Kenbrio Pharmaceuticals Private Limited, buy the company report.
Financials of Kenbrio Pharmaceuticals Private Limited
FY 2025 filings availableKenbrio Pharmaceuticals Private Limited reported revenue of ₹1.05 Cr (down 4% YoY) for FY 2024.
Revenue · FY 2024
₹1.05 Cr ▼ 4%
Net profit · FY 2024
₹3.31 Lakh margin 3.1%
EBITDA · FY 2024
₹4.93 Lakh margin 4.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 37%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 46%
3 years · compounded
▲ 113%
5 years · compounded
▲ 31%
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.93 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.31 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kenbrio Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kenbrio Pharmaceuticals Private Limited
Kenbrio Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeraj Kumar | Director | 13 Oct 2016 | 10 Years 0 Months | Current |
| Rakesh Singh Salaria | Director | 13 Oct 2016 | 10 Years 0 Months | Current |
Auditor
Kenbrio Pharmaceuticals Private Limited is audited by SETHI SETHI & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SETHI SETHI & ASSOCIATES | FY 2017 | 025041N |
Shareholding
The shareholding of Kenbrio Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Kenbrio Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹20.1 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jan 2025 | 101064689 | Hdfc Bank Limited | ₹20.1 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Kenbrio Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kenbrio Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kenbrio Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAGCK3217Q1ZC | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kenbrio Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kenbrio Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Arun Kumar ceased to be Director on 10 Jan 2017.
AGM
Kenbrio Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Kenbrio Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 20.10 Lakh with Charge ID 101064689 was registered on 28 Jan 2025.
Ceased
Arun Kumar ceased to be Director.
Ceased
Deepak Vashisht ceased to be Director.
Appointed
Neeraj Kumar was appointed as Director.
Appointed
Rakesh Singh Salaria was appointed as Director.
Incorporation
13 Oct 2016
Kenbrio Pharmaceuticals Private Limited was registered on 13 Oct 2016 with Roc Chandigarh & aged 10 years 25 days as per MCA records.
Frequently asked questions
Kenbrio Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 October 2016 (10+ years old) and is registered under CIN U24299CH2016PTC041253.
Kenbrio Pharmaceuticals has 2 current directors:
- Neeraj Kumar - Director
- Rakesh Singh Salaria - Director
The latest financial statements of Kenbrio Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Kenbrio Pharmaceuticals is 04AAGCK3217Q1ZC, registered in Chandigarh.
The CIN (Corporate Identification Number) of Kenbrio Pharmaceuticals is U24299CH2016PTC041253. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kenbrio Pharmaceuticals was incorporated on 13 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chandigarh.
Arun Kumar ceased to be Director on 10 Jan 2017. Deepak Vashisht ceased to be Director on 10 Jan 2017. Neeraj Kumar was appointed as Director on 13 Oct 2016. Kenbrio Pharmaceuticals has 4 board changes on record in total.
Yes, Kenbrio Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-CH-01-0009354).
The registered office of Kenbrio Pharmaceuticals is at Shop No. 6 A Plot No. 181 Sp Rana Complex Village – Dadumajra, Chandigarh, India – 160014.
Kenbrio Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages